High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

被引：0
|
作者：
Hui Gao
Joshua M Korn
Stéphane Ferretti
John E Monahan
Youzhen Wang
Mallika Singh
Chao Zhang
Christian Schnell
Guizhi Yang
Yun Zhang
O Alejandro Balbin
Stéphanie Barbe
Hongbo Cai
Fergal Casey
Susmita Chatterjee
Derek Y Chiang
Shannon Chuai
Shawn M Cogan
Scott D Collins
Ernesta Dammassa
Nicolas Ebel
Millicent Embry
John Green
Audrey Kauffmann
Colleen Kowal
Rebecca J Leary
Joseph Lehar
Ying Liang
Alice Loo
Edward Lorenzana
E Robert McDonald
Margaret E McLaughlin
Jason Merkin
Ronald Meyer
Tara L Naylor
Montesa Patawaran
Anupama Reddy
Claudia Röelli
David A Ruddy
Fernando Salangsang
Francesca Santacroce
Angad P Singh
Yan Tang
Walter Tinetto
Sonja Tobler
Roberto Velazquez
Kavitha Venkatesan
Fabian Von Arx
Hui Qin Wang
Zongyao Wang
机构：
[1] Oncology Disease Area,Department of Oncology Translational Medicine
[2] Novartis Institutes for Biomedical Research,undefined
[3] Oncology Disease Area,undefined
[4] Novartis Institutes for Biomedical Research,undefined
[5] Novartis Institutes for Biomedical Research,undefined
[6] China Novartis Institutes for Biomedical Research,undefined
[7] Oncology Disease Area,undefined
[8] Novartis Institutes for Biomedical Research,undefined
[9] Present addresses: Patronus Therapeutics,undefined
[10] Inc.,undefined
[11] San Francisco,undefined
[12] California,undefined
[13] USA (M.S.); Janssen China R&D and Scientific Affairs,undefined
[14] Shanghai,undefined
[15] China (C.Z.); BioMarin Pharmaceutical,undefined
[16] Inc.,undefined
[17] Novato,undefined
[18] California,undefined
[19] USA (N.K.P.); and Duke University,undefined
[20] Durham,undefined
[21] North Carolina,undefined
[22] USA (A.R.).,undefined
来源：
Nature Medicine | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The authors implement a collection of patient-derived xenograft tumors to test cancer drug responses.
引用
收藏
页码：1318 / 1325
页数：7
相关论文
共 50 条
  • [1] High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
    Gao, Hui
    Korn, Joshua M.
    Ferretti, Stephane
    Monahan, John E.
    Wang, Youzhen
    Singh, Mallika
    Zhang, Chao
    Schnell, Christian
    Yang, Guizhi
    Zhang, Yun
    Balbin, O. Alejandro
    Barbe, Stephanie
    Cai, Hongbo
    Casey, Fergal
    Chatterjee, Susmita
    Chiang, Derek Y.
    Chuai, Shannon
    Cogan, Shawn M.
    Collins, Scott D.
    Dammassa, Ernesta
    Ebel, Nicolas
    Embry, Millicent
    Green, John
    Kauffmann, Audrey
    Kowa, Colleen
    Leary, Rebecca J.
    Lehar, Joseph
    Liang, Ying
    Loo, Alice
    Lorenzana, Edward
    McDonald, E. Robert, III
    McLaughlin, Margaret E.
    Merkin, Jason
    Meyer, Ronald
    Naylor, Tara L.
    Patawaran, Montesa
    Reddy, Anupama
    Roeelli, Claudia
    Ruddy, David A.
    Salangsang, Fernando
    Santacroce, Francesca
    Singh, Angad P.
    Tang, Yan
    Tinetto, Walter
    Tobler, Sonja
    Velazquez, Roberto
    Venkatesan, Kavitha
    Von Arx, Fabian
    Wang, Hui Qin
    Wang, Zongyao
    NATURE MEDICINE, 2015, 21 (11) : 1318 - 1325
  • [2] In vivo drug response evaluation in anaplastic thyroid cancer patient-derived tumor xenografts following high-throughput screening
    Maniakas, Anastasios
    Mohamed, Abdallah S.
    Henderson, Ying C.
    Hei, Hu
    Peng, Shaohua
    Bell, Diana
    Williams, Michelle D.
    Scherer, Steve
    Wheeler, David A.
    Clayman, Gary L.
    Zafereo, Mark
    Wang, Jennifer R.
    Cabanillas, Maria E.
    Stephan, Clifford
    Johnson, Faye M.
    Lai, Stephen Y.
    CANCER RESEARCH, 2020, 80 (16)
  • [3] High-throughput screening of patient-derived HCC organoids for drug discovery
    Michelle, Alissa
    Wong, Go
    Cheung, Winnie
    Wong, Maggie
    Wong, Aikha
    Lam, Helena
    Zhang, Zhe
    Man, Matthew
    Chen, Hui
    Close, David
    Johnston, Paul
    Chan, Anthony
    Lai, Paul
    Kwong, Joseph
    Wong, Nathalie
    CANCER RESEARCH, 2020, 80 (16)
  • [4] Patient-Derived Tumor Organoid Rings for Histologic Characterization and High-Throughput Screening
    Nguyen, Huyen Thi Lam
    Soragni, Alice
    STAR PROTOCOLS, 2020, 1 (02):
  • [5] High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids
    Higa, Arisa
    Takahashi, Nobuhiko
    Hiyama, Gen
    Tamura, Hirosumi
    Hoshi, Hirotaka
    Shimomura, Kenju
    Watanabe, Shinya
    Takagi, Motoki
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021, (172):
  • [6] High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts
    Clayton, Stuart A.
    Mizener, Alan D.
    Pugacheva, Elena
    Pistilli, Emidio E.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2024, (214):
  • [7] Optimizing Drug Response Study Design in Patient-Derived Tumor Xenografts
    Weiss, Jessica
    Pham, Nhu-An
    Pintilie, Melania
    Li, Ming
    Liu, Geoffrey
    Shepherd, Frances A.
    Tsao, Ming-Sound
    Xu, Wei
    CANCER INFORMATICS, 2022, 21
  • [8] A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids
    Phan, Nhan
    Hong, Jenny J.
    Tofig, Bobby
    Mapua, Matthew
    Elashoff, David
    Moatamed, Neda A.
    Huang, Jin
    Memarzadeh, Sanaz
    Damoiseaux, Robert
    Soragni, Alice
    COMMUNICATIONS BIOLOGY, 2019, 2 (1)
  • [9] A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids
    Nhan Phan
    Jenny J. Hong
    Bobby Tofig
    Matthew Mapua
    David Elashoff
    Neda A. Moatamed
    Jin Huang
    Sanaz Memarzadeh
    Robert Damoiseaux
    Alice Soragni
    Communications Biology, 2
  • [10] Characterization and High-Throughput Drug Screening of a Cardiomyopathy Using Cardiomyocytes From Patient-Derived Induced Pluripotent Stem Cells
    Rowland, Teisha J.
    Hashem, Sherin I.
    Jones, Kenneth L.
    Adler, Eric D.
    LaBarbera, Daniel V.
    Mestroni, Luisa
    Taylor, Matthew R.
    CIRCULATION, 2016, 134
12345